Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ROBERT Y LIN

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1932244274
CMS profile
269712
Location
GLENDALE, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$2,045.09

98 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,027.09 97
Education $18.00 1

By paying entity

PY2020 · entire year · sorted by reported total

Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ROBERT Y LIN

NPI 1932244274 · CMS profile ID 269712

Allopathic & Osteopathic Physicians / Allergy & Immunology

GLENDALE, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1932244274?year=2020&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ROBERT Y LIN, NPI 1932244274, CMS profile ID 269712. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1932244274?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). ROBERT Y LIN, NPI 1932244274, CMS profile ID 269712. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1932244274?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
ROBERT Y LIN, NPI 1932244274, CMS profile ID 269712, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1932244274?year=2020&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

98 matching records · $2,045.09 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 98 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–98 of 98.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GENZYME CORPORATION $16.7608/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744170501 CMS
GlaxoSmithKline, LLC. $22.3408/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738973013 CMS
PFIZER INC. $16.8708/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743339427 CMS
AstraZeneca Pharmaceuticals LP $15.0808/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736237011 CMS
OptiNose US, Inc. $17.0908/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737162163 CMS
GlaxoSmithKline, LLC. $9.7707/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738495369 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.0907/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 720960271 CMS
Teva Pharmaceuticals USA, Inc. $17.9307/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749528071 CMS
AstraZeneca Pharmaceuticals LP $16.6907/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736201203 CMS
GlaxoSmithKline, LLC. $24.4707/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738749931 CMS
GENZYME CORPORATION $25.1507/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744170461 CMS
PFIZER INC. $29.4407/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743377087 CMS
AstraZeneca Pharmaceuticals LP $12.0707/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736320177 CMS
AstraZeneca Pharmaceuticals LP $10.9707/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736441491 CMS
GlaxoSmithKline, LLC. $22.9107/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738496373 CMS
AstraZeneca Pharmaceuticals LP $12.1607/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736010235 CMS
Grifols USA, LLC $16.2507/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750411265 CMS
AstraZeneca Pharmaceuticals LP $24.7506/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736091807 CMS
GlaxoSmithKline, LLC. $24.6706/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738647879 CMS
AstraZeneca Pharmaceuticals LP $20.6406/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735819515 CMS
Eyevance Pharmaceuticals LLC $19.1706/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753060215 CMS
GENZYME CORPORATION $23.4706/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744170451 CMS
Genentech USA, Inc. $18.7706/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743094919 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.9505/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 720960279 CMS
GlaxoSmithKline, LLC. $27.4805/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738575091 CMS
AstraZeneca Pharmaceuticals LP $24.7305/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735804421 CMS
GENZYME CORPORATION $28.7905/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744170449 CMS
ALK-Abello, Inc $19.2005/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748138827 CMS
AstraZeneca Pharmaceuticals LP $18.5905/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735755183 CMS
Genentech USA, Inc. $18.5005/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743094913 CMS
GlaxoSmithKline, LLC. $24.9205/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738579063 CMS
AstraZeneca Pharmaceuticals LP $17.6305/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735888779 CMS
Eyevance Pharmaceuticals LLC $18.1504/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753060213 CMS
Optinose US, Inc. $20.2504/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737162185 CMS
AstraZeneca Pharmaceuticals LP $18.0004/15/2020 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736211167 CMS
GlaxoSmithKline, LLC. $20.9903/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738663843 CMS
Regeneron Healthcare Solutions, Inc. $29.2403/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 724435151 CMS
Novartis Pharmaceuticals Corporation $21.5703/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725993369 CMS
AstraZeneca Pharmaceuticals LP $21.0502/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736215063 CMS
GlaxoSmithKline, LLC. $13.3602/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738852909 CMS
Regeneron Healthcare Solutions, Inc. $27.1102/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 724435147 CMS
GlaxoSmithKline, LLC. $8.1202/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738605311 CMS
Genentech USA, Inc. $17.4502/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743094907 CMS
PFIZER INC. $15.3501/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743360387 CMS
Regeneron Healthcare Solutions, Inc. $23.4901/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 724435145 CMS
Novartis Pharmaceuticals Corporation $19.7601/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725993367 CMS
Novartis Pharmaceuticals Corporation $21.9601/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725993365 CMS
Genentech USA, Inc. $15.1401/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743094903 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,201.49 80
PY2020 $2,045.09 98
PY2021 $2,565.52 118
PY2022 $3,674.02 181
PY2023 $3,628.49 155
PY2024 $3,703.99 149
PY2025 $4,104.62 146

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $5,092.94 13
PY2024 Principal investigator $17,976.55 37
PY2023 Principal investigator $15,799.01 7
PY2022 Recipient $2,033.68 5
PY2022 Principal investigator $7,842.31 3
PY2021 Recipient $3,696.15 6
PY2021 Principal investigator $9,741.05 3
PY2020 Principal investigator $13,925.80 3
PY2019 Principal investigator $39,718.85 30

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

13 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $600.00 11/11/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184259305
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $290.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214946
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $600.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214948
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $290.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214950
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $600.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214952
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $600.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214954
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $290.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214956
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $290.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214958
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $290.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214960
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $290.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214962
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $290.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214964
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $290.00 07/15/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS GROUP PLLC
A PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS No dispute reported 06/30/2026 1184214966
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $372.94 07/02/2025 Non-covered Recipient Entity
NEW YORK ALLERGY AND SINUS CENTER
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184212427